Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The incidence of type 2 diabetes is on the increase. According to recent Canadian Diabetes
Association guidelines glucose control, based on the A1C measurement, needs to be achieved
within a 6-12 month period of time after the initial diagnosis of type 2 diabetes. The
guidelines on the use of antihyperglycemic agents identify the potential benefits of
sub-maximal oral combination therapy in order to achieve more rapid and improved glycemic
control compared with higher dose monotherapy. Furthermore, many patients on prolonged oral
antihyperglycemic monotherapy who then start on combination therapy may not achieve the
required target glycemic control. Indeed early initiation of combination therapies may be
necessary to achieve and maintain glycemic targets because of the progressive deterioration
of pancreatic β cell function and glycemic control.